Coronary disease & ACSRandomised controlled trial

Intravascular Ultrasound vs Angiography-Guided Drug-Coated Balloon Angioplasty

JACC Cardiovasc IntervPublished

  • Randomised controlled trial

Authors' conclusion

This study demonstrated that IVUS-guided DCB angioplasty is associated with a lower LLL in patients with a de novo coronary lesion compared with angiography guidance.

Study context

Population
Patients with high bleeding risk and a de novo coronary lesion (reference vessel diameter 2.0–4.0 mm, lesion length ≤15 mm)
Participants
260 patients
Comparison
Intravascular ultrasound (IVUS)-guided vs angiography-guided drug-coated balloon (DCB) angioplasty
Primary endpoint
In-segment late lumen loss (LLL)
Follow-up
7 months after procedure

Primary result

In-segment LLL · 7 months

Mean difference

0.14 mm

95% CI 0.02–0.26

P = 0.025

By group

Angiography guidance

0.03

mean · SD 0.52 · mm

IVUS guidance

−0.10

mean · SD 0.34 · mm

Angiography guidance vs IVUS guidance
mean difference 0.14 mm (95% CI 0.02–0.26); P = 0.025

As reported in the abstract

Secondary outcomes

OutcomeValuesP value
Target vessel failure · 6 monthsAngiography-guided 3.1% · IVUS-guided 0.8%P = 0.370
Minimal lumen diameter · 7 monthsP < 0.001
Diameter stenosis · 7 monthsP = 0.001

Safety

events

OutcomeAngiography-guidedIVUS-guidedP value
Bailout stent implantation27P = 0.172

Original publication

Intravascular Ultrasound vs Angiography-Guided Drug-Coated Balloon Angioplasty. JACC Cardiovasc Interv. Published 5 June 2024. doi:10.1016/j.jcin.2024.04.014

Summarised from the published abstract; every number is checked against it